IMMUNOGENE ZUSAMMENSETZUNG

Patent europeic · EP2928489 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2928489
Numer da la dumonda
EP13801540
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
03-12-2013
Publitgà
14-10-2015
Concedì
27-02-2019
La protecziun finescha il pli tard
02-12-2033
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
A61K 39/08 (2006.01)
C07K 14/33 (2006.01)
Prioritad
GB 201221875 05.12.2012
Dumonda PCT
PCT/EP2013/075405 03.12.2013
Publicaziun PCT
WO2014/086787 12.06.2014
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-01-2026

    Midada

    Published in Swissreg on 01.01.2026

  2. 01-01-2025

    Midada

    Published in Swissreg on 01.01.2025

  3. 01-01-2024

    Midada

    Published in Swissreg on 01.01.2024

  4. 01-01-2023

    Midada

    Published in Swissreg on 01.01.2023

  5. 15-03-2019

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 15.03.2019

  6. 27-02-2019

    Concedì

    Published in Swissreg on 27.02.2019

Partidas

Possessur

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut, 89, 1330 Rixensart, BE

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

WALLEMACQ, Hugues

1330 Rixensart, BE

BOUTRIAU, Dominique

1330 Rixensart, BE

GERMAIN, Sophie Marie Jeanne Valentine

1330 Rixensart, BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.